Pharmasset, Inc. (NASDAQ:VRUS.DL)

CAPS Rating: No stars

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

VRUS.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top VRUS.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

raffaeled (< 20)
Submitted March 01, 2011

by far the best hcv drug candidates

PWorm (44.95)
Submitted July 28, 2011

Wow. Just wow. These numbers look horrible. The only justification for this price point is mafia.--P-Worm

VRUS.DL VS S&P 500 (SPY)

VRUS.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about VRUS.DL.

No one has written a Pitch for VRUS.DL stock yet. Tell us why you think VRUS.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in VRUS.DL.

No players have picked VRUS.DL yet. Tell us why you think VRUS.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUltraLong < 20 11/4/2011 Underperform NS $73.64 +86.00% +3.28% -82.72 1/18/2012 @ $136.97 1 Comment
TrackJimCramer 85.44 9/6/2011 Outperform 3W $70.53 +94.20% +10.56% +83.64 1/18/2012 @ $136.97 0 Comment
TrackJimCramer 85.44 6/9/2011 Underperform 3W $61.33 +15.01% -8.32% -23.33 9/6/2011 @ $70.53 0 Comment
TrackBreanMurray 76.96 6/2/2011 Outperform NS $49.22 +172.23% -9.85% +182.08 11/22/2011 @ $133.99 0 Comment
trackthinkequity 86.53 3/8/2011 Outperform NS $31.79 +330.86% -1.75% +332.61 1/18/2012 @ $136.97 0 Comment
TrackJimCramer 85.44 10/12/2010 Outperform 3W $15.87 +286.54% +10.59% +275.95 6/9/2011 @ $61.33 0 Comment
TrackMPAdvisors < 20 9/14/2010 Outperform NS $13.95 +882.22% +14.79% +867.43 1/18/2012 @ $136.97 0 Comment
TrackJPMorgan 87.87 4/13/2010 Outperform NS $14.11 +14.81% -0.68% +15.49 4/30/2010 @ $16.20 0 Comment
TrackCitigroup 92.73 3/16/2010 Outperform NS $12.11 +1,031.52% +11.68% +1,019.83 1/18/2012 @ $136.97 0 Comment
TrackRWBaird 88.57 9/9/2009 Outperform NS $10.13 +1,136.64% +18.97% +1,117.67 12/16/2011 @ $125.21 0 Comment
TrackWedbush 88.87 3/18/2009 Outperform NS $4.68 +2,829.84% +66.27% +2,763.57 1/18/2012 @ $136.97 0 Comment
trackthinkequity 86.53 1/27/2009 Outperform NS $5.38 +322.42% +51.47% +270.95 1/7/2011 @ $22.71 0 Comment
TrackRothCapital 72.38 12/5/2008 Underperform NS $6.25 -24.64% -14.39% +10.25 3/3/2009 @ $4.71 0 Comment
TrackCowenandCo 84.55 10/29/2008 Outperform NS $8.22 +1,567.32% +38.58% +1,528.73 1/18/2012 @ $136.97 0 Comment
TrackLazardCapit 83.22 10/21/2008 Outperform NS $10.78 +1,171.18% +33.35% +1,137.83 1/18/2012 @ $136.97 0 Comment
TrackLeerinkSwan 95.68 7/28/2008 Outperform NS $9.29 +1,374.38% +3.05% +1,371.33 1/18/2012 @ $136.97 0 Comment
TrackPacificGrow < 20 5/21/2008 Outperform NS $8.87 +1,444.19% -7.40% +1,451.59 1/18/2012 @ $136.97 0 Comment
TrackUBS 92.16 4/2/2008 Outperform NS $10.00 +1,240.00% -12.86% +1,252.86 11/22/2011 @ $134.00 0 Comment
trackmerriman 69.83 3/11/2008 Outperform NS $7.80 +1,656.03% -1.06% +1,657.08 1/18/2012 @ $136.97 0 Comment
TrackSusquehanna 91.92 12/7/2007 Outperform NS $7.08 +1,835.97% -14.58% +1,850.55 1/18/2012 @ $136.97 0 Comment
TrackUBS 92.16 6/11/2007 Outperform NS $4.43 +137.85% -9.54% +147.39 2/19/2008 @ $10.53 0 Comment
TrackStifel 92.01 6/8/2007 Outperform NS $4.38 +128.57% -4.69% +133.26 1/8/2008 @ $10.00 0 Comment
TrackJMP 83.19 6/7/2007 Outperform NS $4.45 +2,977.98% -14.66% +2,992.64 1/18/2012 @ $136.97 0 Comment
TrackBofASec 94.06 6/6/2007 Outperform NS $4.50 +2,943.78% -15.41% +2,959.19 1/18/2012 @ $136.97 0 Comment

Featured Broker Partners